PBI
59
-7
CVS
31
2
CFG
46
2
CA
25
-7
SPG
53
2
AVGO
88
27
IPG
49
2
LYB
25
-14
KEY
31
2
NEM
46
-2
MCHP
43
6
MLM
41
-2
CCL
68
-2
TAP
60
2
STX
42
-2
ROK
52
-2
TSN
28
-2
CRM
72
-3
RSG
62
-2
AKAM
59
-2
PBI
59
-7
CVS
31
2
CFG
46
2
CA
25
-7
SPG
53
2
AVGO
88
27
IPG
49
2
LYB
25
-14
KEY
31
2
NEM
46
-2
MCHP
43
6
MLM
41
-2
CCL
68
-2
TAP
60
2
STX
42
-2
ROK
52
-2
TSN
28
-2
CRM
72
-3
RSG
62
-2
AKAM
59
-2
Financhill
Back

Galera Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
17

GRTX
Galera Therapeutics

Last Price:
0.03
Seasonality Move:
31.34%
Sell
23

NBY
NovaBay Pharmaceuticals

Last Price:
0.58
Seasonality Move:
-6.51%
Sell
17
Galera Therapeutics (GRTX) is a Sell

Is Galera Therapeutics a Buy, Sell or Hold?

  • The current Galera Therapeutics [GRTX] share price is $0.03. The Score for GRTX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • GRTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GRTX Stock Price Chart

What is Galera Therapeutics's stock price today?

  • The Galera Therapeutics share price today is $0.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

GRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 29.08 Sell
Chaikin Money Flow: 224916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.03 - 0.05) Sell
Bollinger Bands (100): (0.05 - 0.09) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.63 Sell
Chaikin Money Flow: 40319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.57 - 0.71) Sell
Bollinger Bands (100): (0.4 - 0.86) Sell

GRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.03 Sell
20-day SMA: 0.04 Sell
50-day SMA: 0.05 Sell
200-day SMA: 0.12 Sell
8-day EMA: 0.03 Sell
20-day EMA: 0.04 Sell
50-day EMA: 0.05 Sell
200-day EMA: 0.18 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Buy
20-day SMA: 0.62 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.61 Sell
50-day EMA: 0.67 Sell
200-day EMA: 4.92 Sell

Galera Therapeutics Earnings Growth & GRTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and a decrease next year of $0.00 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Galera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):